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Introduction
Because of increasing prevalence of multi-drug resistant
(MDR) pathogens, there are many difficulties in the treat-
ment of hospital-acquired pneumonia (HAP)/ventilator-
associated pneumonia (VAP). It is known that patients
with MDR pathogens have high mortality and morbidity.
We need to know the current status of pathogens and
antibiotics therapy for a proper choice of initial antibiotics
to improve outcome of the patients.
Objectives
This study was aimed at investigating the current patho-
gens and treatment of HAP/VAP in Korean ICUs.
Methods A prospective, multicenter and observational
study was conducted in six tertiary referral hospitals in
Korea between August 1, 2012 and July 31, 2013. This
study included patients who were admitted to adult
medical ICUs with diagnosed as pneumonia developing
at least 48 hours after admission or initiation of
mechanical ventilation. We analyzed the prevalence of
their pathogens, and treatment and clinical courses of
these patients.
Results
During the study period of 12 months, total 134 patients
with HAP/VAP were enrolled. Mean age was 65 with
103 (77%) males. Forty-seven (35%) patients had risk
factors of MDR pathogens. The duration between
admission and diagnosis of pneumonia was 12 days
(IQR: 7-22 days). Most of patients (86%) underwent
mechanical ventilation. Pathogens were identified in
79 (59%) patients. Among them, MDR bacteria were iso-
lated in 55 (76%) patients. The most common MDR
pathogen was carbapenem-resistant Acinetobacter bau-
mannii (60%). However, extended-spectrum penicillin/b-
lactamase inhibitor-based was the most common
empirical antibiotics (39%) during initial 48 hours after
diagnosis. Glycopeptides were used in 60 patients (47%).
As a subsequent therapy between 48 hours and 2 weeks
after diagnosis, carbapenem-based regimen was most
common (36%). On the other hand, colistin-based ther-
apy was done in 29 (22%) patients. Only 45 (34%)
patients showed a clinical resolution within 28 days.
They showed a high in-hospital mortality of 51% with
28-day and 60-day of 31% and 49%, respectively.
Conclusions
This study demonstrates that carbapenem-resistant A.
baumannii is the most common MDR pathogen in Korean
medical ICUs. It shows that there is a discrepancy between
the common MDR pathogen and the choice of empirical
antibiotic therapy.
Authors’ details
1Chungbuk National Univ. Hospital, Chungbuk National University College of
Medicine, Division of Pulmonary and Critical Care Medicine, Department of
Internal Medicine, Cheongju, Korea, Republic of. 2Chungnam National Univ.
Hospital, Chungnam National University College of Medicine, Division of
Pulmonary and Critical Care Medicine, Department of Internal Medicine,
Daejeon, Korea, Republic of. 3Seoul National University Bundang Hospital,
Seoul National University College of Medicine, Division of Pulmonary and
Critical Care Medicine, Department of Internal Medicine, Seongnam, Korea,
Republic of. 4Seoul National University Hospital, Seoul National University
College of Medicine, Division of Pulmonary and Critical Care Medicine,
Department of Internal Medicine, Seoul, Korea, Republic of. 5Samsung
Medical Center, Sungkyunkwan University School of Medicine, Department
of Pulmonary and Critical Care Medcine, Seoul, Korea, Republic of. 6St.Mary’s
Hospital, The Catholic University of Korea, Division of Pulmonology,
Department of Internal Medicine, Seoul, Korea, Republic of. 7Asan Medical
1Chungbuk National Univ. Hospital, Chungbuk National University College of
Medicine, Division of Pulmonary and Critical Care Medicine, Department of
Internal Medicine, Cheongju, Korea, Republic of
Full list of author information is available at the end of the article
Chang et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A707
http://www.icm-experimental.com/content/3/S1/A707
© 2015 Chang et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
Center, University of Ulsan College of Medicine, Department of Infectious
Diseases, Seoul, Korea, Republic of. 8Severance Hospital, Yonsei University
College of Medicine, Division of Pulmonology, Department of Internal
Medicine, Seoul, Korea, Republic of. 9Asan Medical Center, University of
Ulsan College of Medicine, Department of Pulmonary and Critical Care
Medicine, Seoul, Korea, Republic of.
Published: 1 October 2015
References
1. Weber DJ, Rutala WA, Sickbert-Bennett EE, et al: Infect Control Hosp
Epidemiol. 2007, 28(825).
2. Kollef MH, Morrow LE, Niederman MS, et al: Chest 2006, 129(1210).
3. American Thoracic Society, Infectious Diseases Society of America: Am J
Respir Crit Care Med 2005, 171(388).
4. Kollef MH, Shorr A, Tabak YP, et al: Chest 2005, 128-3854.
5. Paterson DL: Clin Infect Dis 2006, 43(Suppl 2):S43.
doi:10.1186/2197-425X-3-S1-A707
Cite this article as: Chang et al.: The current pathogens and treatment
of hospital-acquired pneumonia/ventilator-associated pneumonia in
medical intensive care units. Intensive Care Medicine Experimental 2015
3(Suppl 1):A707.
Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Chang et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A707
http://www.icm-experimental.com/content/3/S1/A707
Page 2 of 2
